-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Molecular -X- _ O
diagnostic -X- _ O
methods -X- _ O
can -X- _ O
complement -X- _ O
existing -X- _ O
tools -X- _ O
to -X- _ O
improve -X- _ O
the -X- _ O
diagnosis -X- _ B-Patient
of -X- _ I-Patient
malaria. -X- _ I-Patient
However -X- _ O
, -X- _ O
they -X- _ O
require -X- _ O
good -X- _ O
laboratory -X- _ O
infrastructure -X- _ O
thereby -X- _ O
restricting -X- _ O
their -X- _ O
use -X- _ O
to -X- _ O
reference -X- _ O
laboratories -X- _ O
and -X- _ O
research -X- _ O
studies. -X- _ O
Therefore -X- _ O
, -X- _ O
adopting -X- _ O
molecular -X- _ O
tools -X- _ O
for -X- _ O
routine -X- _ O
use -X- _ O
in -X- _ O
malaria -X- _ O
endemic -X- _ O
countries -X- _ O
will -X- _ O
require -X- _ O
simpler -X- _ O
molecular -X- _ O
platforms. -X- _ O
The -X- _ O
recently -X- _ O
developed -X- _ O
loop-mediated -X- _ B-Intervention
isothermal -X- _ I-Intervention
amplification -X- _ I-Intervention
( -X- _ I-Intervention
LAMP -X- _ I-Intervention
) -X- _ I-Intervention
method -X- _ O
is -X- _ O
relatively -X- _ O
simple -X- _ O
and -X- _ O
can -X- _ O
be -X- _ O
improved -X- _ O
for -X- _ O
better -X- _ O
use -X- _ O
in -X- _ O
endemic -X- _ O
countries. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
attempted -X- _ O
to -X- _ O
improve -X- _ O
this -X- _ O
method -X- _ O
for -X- _ O
malaria -X- _ B-Patient
diagnosis -X- _ I-Patient
by -X- _ O
using -X- _ O
a -X- _ O
simple -X- _ O
and -X- _ O
portable -X- _ O
device -X- _ O
capable -X- _ O
of -X- _ O
performing -X- _ O
both -X- _ O
the -X- _ O
amplification -X- _ B-Intervention
and -X- _ I-Intervention
detection -X- _ I-Intervention
( -X- _ I-Intervention
by -X- _ I-Intervention
fluorescence -X- _ I-Intervention
) -X- _ I-Intervention
of -X- _ I-Intervention
LAMP -X- _ I-Intervention
in -X- _ O
one -X- _ O
platform. -X- _ O
We -X- _ O
refer -X- _ O
to -X- _ O
this -X- _ O
as -X- _ O
the -X- _ O
RealAmp -X- _ B-Intervention
method. -X- _ I-Intervention
METHODOLOGY -X- _ O
AND -X- _ O
SIGNIFICANT -X- _ O
FINDINGS -X- _ O
: -X- _ O
Published -X- _ O
genus-specific -X- _ O
primers -X- _ O
were -X- _ O
used -X- _ O
to -X- _ O
test -X- _ O
the -X- _ O
utility -X- _ O
of -X- _ O
this -X- _ O
method. -X- _ O
DNA -X- _ O
derived -X- _ O
from -X- _ O
different -X- _ O
species -X- _ O
of -X- _ O
malaria -X- _ O
parasites -X- _ O
was -X- _ O
used -X- _ O
for -X- _ O
the -X- _ O
initial -X- _ O
characterization. -X- _ O
Clinical -X- _ O
samples -X- _ O
of -X- _ O
P. -X- _ O
falciparum -X- _ O
were -X- _ O
used -X- _ O
to -X- _ O
determine -X- _ O
the -X- _ O
sensitivity -X- _ O
and -X- _ O
specificity -X- _ O
of -X- _ O
this -X- _ O
system -X- _ O
compared -X- _ O
to -X- _ O
microscopy -X- _ B-Comparison
and -X- _ I-Comparison
a -X- _ I-Comparison
nested -X- _ I-Comparison
PCR -X- _ I-Comparison
method. -X- _ I-Comparison
Additionally -X- _ O
, -X- _ O
directly -X- _ O
boiled -X- _ O
parasite -X- _ O
preparations -X- _ O
were -X- _ O
compared -X- _ O
with -X- _ O
a -X- _ O
conventional -X- _ O
DNA -X- _ O
isolation -X- _ O
method. -X- _ O
The -X- _ B-Outcome
RealAmp -X- _ I-Outcome
method -X- _ I-Outcome
was -X- _ I-Outcome
found -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
simple -X- _ I-Outcome
and -X- _ I-Outcome
allowed -X- _ I-Outcome
real-time -X- _ I-Outcome
detection -X- _ I-Outcome
of -X- _ I-Outcome
DNA -X- _ I-Outcome
amplification. -X- _ I-Outcome
The -X- _ I-Outcome
time -X- _ I-Outcome
to -X- _ I-Outcome
amplification -X- _ I-Outcome
varied -X- _ I-Outcome
but -X- _ I-Outcome
was -X- _ I-Outcome
generally -X- _ I-Outcome
less -X- _ I-Outcome
than -X- _ I-Outcome
60 -X- _ I-Outcome
minutes. -X- _ I-Outcome
All -X- _ I-Outcome
human-infecting -X- _ I-Outcome
Plasmodium -X- _ I-Outcome
species -X- _ I-Outcome
were -X- _ I-Outcome
detected. -X- _ I-Outcome
The -X- _ I-Outcome
sensitivity -X- _ I-Outcome
and -X- _ I-Outcome
specificity -X- _ I-Outcome
of -X- _ I-Outcome
RealAmp -X- _ I-Outcome
in -X- _ I-Outcome
detecting -X- _ I-Outcome
P. -X- _ I-Outcome
falciparum -X- _ I-Outcome
was -X- _ I-Outcome
96.7 -X- _ I-Outcome
% -X- _ I-Outcome
and -X- _ I-Outcome
91.7 -X- _ I-Outcome
% -X- _ I-Outcome
respectively -X- _ I-Outcome
, -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
microscopy -X- _ I-Outcome
and -X- _ I-Outcome
98.9 -X- _ I-Outcome
% -X- _ I-Outcome
and -X- _ I-Outcome
100 -X- _ I-Outcome
% -X- _ I-Outcome
respectively -X- _ I-Outcome
, -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
a -X- _ I-Outcome
standard -X- _ I-Outcome
nested -X- _ I-Outcome
PCR -X- _ I-Outcome
method. -X- _ I-Outcome
In -X- _ I-Outcome
addition -X- _ I-Outcome
, -X- _ I-Outcome
this -X- _ I-Outcome
method -X- _ I-Outcome
consistently -X- _ I-Outcome
detected -X- _ I-Outcome
P. -X- _ I-Outcome
falciparum -X- _ I-Outcome
from -X- _ I-Outcome
directly -X- _ I-Outcome
boiled -X- _ I-Outcome
blood -X- _ I-Outcome
samples. -X- _ I-Outcome
CONCLUSION -X- _ O
: -X- _ O
This -X- _ O
RealAmp -X- _ B-Outcome
method -X- _ I-Outcome
has -X- _ I-Outcome
great -X- _ I-Outcome
potential -X- _ I-Outcome
as -X- _ I-Outcome
a -X- _ I-Outcome
field -X- _ I-Outcome
usable -X- _ I-Outcome
molecular -X- _ I-Outcome
tool -X- _ I-Outcome
for -X- _ I-Outcome
diagnosis -X- _ I-Outcome
of -X- _ I-Outcome
malaria. -X- _ I-Outcome
This -X- _ O
tool -X- _ O
can -X- _ O
provide -X- _ O
an -X- _ O
alternative -X- _ O
to -X- _ O
conventional -X- _ O
PCR -X- _ O
based -X- _ O
diagnostic -X- _ O
methods -X- _ O
for -X- _ O
field -X- _ O
use -X- _ O
in -X- _ O
clinical -X- _ O
and -X- _ O
operational -X- _ O
programs -X- _ O
. -X- _ O

